Nagai Shunji, Safwan Mohamed, Collins Kelly, Schilke Randolph E, Rizzari Michael, Moonka Dilip, Brown Kimberly, Patel Anita, Yoshida Atsushi, Abouljoud Marwan
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, USA.
Gastroenterology, Henry Ford Hospital, Detroit, MI, USA.
Transpl Int. 2018 May 2. doi: 10.1111/tri.13275.
The new Organ Procurement and Transplant Network/United Organ Sharing Network (OPTN/UNOS) simultaneous liver-kidney transplant (SLK) policy has been implemented. The aim of this study was to review liver transplant outcomes utilizing the new SLK policy. Liver transplant alone (LTA) and SLK patients between 2009 and 2015 were reviewed. Graft survival and post-transplant kidney function were investigated among LTA patients meeting the chronic kidney disease (CKD) criteria of the new policy (LTA-CKD group). To validate our findings, we reviewed and applied our analysis to the OPTN/UNOS registry. A total of 535 patients were eligible from our series. The LTA-CKD group (n = 27) showed worse 1-year graft survival, compared with the SLK group (n = 44), but not significant (81% vs. 93%, P = 0.15). The LTA-CKD group significantly increased a risk of post-transplant dialysis (odds ratio = 5.59 [95% CI = 1.27-24.7], P = 0.02 [Ref. normal kidney function]). Post-transplant dialysis was an independent risk factor for graft loss (hazard ratio = 7.25, 95% CI = 3.3-15.91, P < 0.001 [Ref. SLK]). In the validation analysis based on the OPTN/UNOS registry, the hazard of 1-year-graft loss in the LTA-CKD group (n = 751) was 34.8% higher than the SLK group (n = 2856) (hazard ratio = 1.348, 95% CI = 1.157-1.572, P < 0.001). Indicating SLK for patients who meet the CKD criteria may significantly improve transplant outcomes.
新的器官获取与移植网络/联合器官共享网络(OPTN/UNOS)同期肝肾联合移植(SLK)政策已实施。本研究的目的是利用新的SLK政策回顾肝移植结果。对2009年至2015年间单纯肝移植(LTA)和SLK患者进行了回顾。在符合新政策慢性肾脏病(CKD)标准的LTA患者(LTA-CKD组)中调查移植物存活情况和移植后肾功能。为验证我们的研究结果,我们对OPTN/UNOS登记处进行了回顾并将分析应用于此。我们的系列研究共有535例患者符合条件。与SLK组(n = 44)相比,LTA-CKD组(n = 27)的1年移植物存活率较差,但差异无统计学意义(81%对93%,P = 0.15)。LTA-CKD组移植后透析风险显著增加(比值比 = 5.59 [95%可信区间 = 1.27 - 24.7],P = 0.02 [参照正常肾功能])。移植后透析是移植物丢失的独立危险因素(风险比 = 7.25,95%可信区间 = 3.3 - 15.91,P < 0.001 [参照SLK])。在基于OPTN/UNOS登记处的验证分析中,LTA-CKD组(n = 751)1年移植物丢失风险比SLK组(n = 2856)高34.8%(风险比 = 1.348,95%可信区间 = 1.157 - 1.572,P < 0.001)。表明对于符合CKD标准的患者进行SLK可能显著改善移植结果。